KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Receivables (2016 - 2025)

Edwards Lifesciences has reported Receivables over the past 17 years, most recently at $912.1 million for Q4 2025.

  • Quarterly results put Receivables at $912.1 million for Q4 2025, up 520.05% from a year ago — trailing twelve months through Dec 2025 was $912.1 million (up 520.05% YoY), and the annual figure for FY2025 was $912.1 million, up 520.05%.
  • Receivables for Q4 2025 was $912.1 million at Edwards Lifesciences, up from $892.8 million in the prior quarter.
  • Over the last five years, Receivables for EW hit a ceiling of $912.1 million in Q4 2025 and a floor of $147.1 million in Q4 2024.
  • Median Receivables over the past 5 years was $765.6 million (2023), compared with a mean of $738.8 million.
  • Biggest five-year swings in Receivables: tumbled 82.24% in 2024 and later surged 520.05% in 2025.
  • Edwards Lifesciences' Receivables stood at $664.9 million in 2021, then rose by 5.14% to $699.1 million in 2022, then rose by 18.45% to $828.1 million in 2023, then tumbled by 82.24% to $147.1 million in 2024, then surged by 520.05% to $912.1 million in 2025.
  • The last three reported values for Receivables were $912.1 million (Q4 2025), $892.8 million (Q3 2025), and $902.6 million (Q2 2025) per Business Quant data.